Patent ID: 11952376
Assignee: PLIANT THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 83:
84. The compound of claim 81, or a pharmaceutically acceptable salt, stereoisomer, or tautomer thereof, wherein:
R2f is C3-C6 cycloalkyl, wherein the C3-C6 cycloalkyl is substituted by 1, 2, 3, 4, or 5 independently selected R2i substituents; and
at least one R2i is phenyl and pyrazolyl, wherein the phenyl or pyrazolyl is optionally substituted by 1, 2, or 3 independently selected R4a substituents; and, each R4a is C1-C6 alkyl.